Overview

A Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Abalparatide Injection and the Reference Formulation Abalparatide Injection (Tymlos) in Healthy Adult Subjects

Status:
NOT_YET_RECRUITING
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
To investigate the pharmacokinetics of the test preparation abalparatide injection and the reference preparation abalparatide injection (Tymlos) in healthy adult subjects under fasting state, and to evaluate the bioequivalence of the two formulations under fasting state.
Phase:
PHASE1
Details
Lead Sponsor:
The Affiliated Hospital of Qingdao University